Metastatic Prostate Cancer
- PMID: 29412780
- DOI: 10.1056/NEJMra1701695
Metastatic Prostate Cancer
Comment in
-
Metastatic Prostate Cancer.N Engl J Med. 2018 Apr 26;378(17):1653. doi: 10.1056/NEJMc1803343. N Engl J Med. 2018. PMID: 29697920 No abstract available.
Similar articles
-
Abiraterone and increased survival in metastatic prostate cancer.N Engl J Med. 2011 Aug 25;365(8):766; author reply 767-8. doi: 10.1056/NEJMc1107198. N Engl J Med. 2011. PMID: 21864182 No abstract available.
-
Comparative Effectiveness of All Available Treatments for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-analysis.Am J Ther. 2020 Sep/Oct;27(5):e541-e543. doi: 10.1097/MJT.0000000000001008. Am J Ther. 2020. PMID: 31107252 No abstract available.
-
Expanding treatment options for metastatic prostate cancer.N Engl J Med. 2011 May 26;364(21):2055-8. doi: 10.1056/NEJMe1102758. N Engl J Med. 2011. PMID: 21612475 Free PMC article. No abstract available.
-
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.BJU Int. 2005 Dec;96(9):1241-6. doi: 10.1111/j.1464-410X.2005.05821.x. BJU Int. 2005. PMID: 16287438 Review. No abstract available.
-
Chemotherapy for metastatic castrate-sensitive prostate cancer.Prostate Cancer Prostatic Dis. 2016 Jun;19(2):139-44. doi: 10.1038/pcan.2016.10. Epub 2016 Mar 15. Prostate Cancer Prostatic Dis. 2016. PMID: 26976365 Review.
Cited by
-
Sequential versus concomitant treatment of androgen receptor signaling inhibitors and docetaxel for metastatic hormone-sensitive prostate cancer: an network meta-analysis.Front Pharmacol. 2024 Oct 28;15:1462360. doi: 10.3389/fphar.2024.1462360. eCollection 2024. Front Pharmacol. 2024. PMID: 39529878 Free PMC article.
-
Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model.Eur J Nucl Med Mol Imaging. 2024 Oct 12. doi: 10.1007/s00259-024-06945-x. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39394527
-
Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [ 177 Lu]Lu-PSMA-617 Radioligand Therapy.Indian J Radiol Imaging. 2024 Feb 23;34(4):579-587. doi: 10.1055/s-0044-1779634. eCollection 2024 Oct. Indian J Radiol Imaging. 2024. PMID: 39318581 Free PMC article.
-
The Circulating miR-107 as a Potential Biomarker Up-Regulated in Castration-Resistant Prostate Cancer.Noncoding RNA. 2024 Aug 24;10(5):47. doi: 10.3390/ncrna10050047. Noncoding RNA. 2024. PMID: 39311384 Free PMC article.
-
Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET.Cancer Imaging. 2024 Sep 19;24(1):126. doi: 10.1186/s40644-024-00773-w. Cancer Imaging. 2024. PMID: 39300507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical